Skip to main content

Day: March 25, 2026

gategroup FY 2025 Trading Update

ZURICH, Switzerland, March 25, 2026: gategroup Holding AG (“gategroup”) today announces preliminary, unaudited key financial results for the financial year ending 31 December 2025. For the period, the company generated revenues of EUR 5.61 billion (2024: EUR 5.47 billion), with EBITDA reaching EUR 467 million (2024: EUR 410 million), resulting in an EBITDA margin of 8.3 percent (2024: 7.5 percent). Net debt/ EBITDA stood at 3.25x (2024: 3.74x) and gross capital expenditures for the period amounted to EUR 88 million (2024: EUR 72 million)1. In line with the Group’s strategy to better align its financial presentation with the currency in which it generates the majority of its revenues and the denominational structure of its global operations, gategroup is transitioning its reporting currency from Swiss Francs (CHF) to Euros (EUR), starting...

Continue reading

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory

DIJON, France – 25 March 2026 (07:20 AM CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing products for emergency situations based on its proprietary ZENEO® needle-free auto-injector technology, currently in the advanced stages of development and registration of ZEPIZURE®, an injectable for the management of epileptic seizures, today publishes its financial results for the financial year ended 31 December 2025. Continued progress on the industrial and regulatory priorities for ZEPIZURE®. Stronger support from BARDA, with total funding increased to $43.3 million. Development of the ZENEO® platform, notably for intramuscular administration, ZEPIZURE® Junior. Operating revenue up 12.25% to €14.9 million. Operating result improved to -€11.6 million (vs -€13.0 million published in 2024 and -€14.2...

Continue reading

Zelluna ASA [ZLNA]: Annual Report 2025

Oslo, Norway, 25 March 2026 – Zelluna ASA, a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, announces that the Board of Directors of Zelluna ASA has approved the Annual Report for 2025.  A PDF version of the Annual Report, as well as the report in European Single Electronic Format (ESEF), are attached to this release. The Annual Report is also available on the company’s website: www.zelluna.com This information is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act. For further information, please contact: Anders Tuv, Chairman of the Board of Directors of Zelluna ASAEmail: at@radforsk.noPhone: +47 982 06 826 Namir Hassan, CEO, Zelluna ASAEmail: namir.hassan@zelluna.com Phone:...

Continue reading

OVHcloud announces the acquisition of Dragon LLM, a developer of specialized generative AI models, and is launching its AI lab to offer new services to its customers based on LLMs

Roubaix – March 25th, 2026 – OVHcloud, a sovereign, global player and European leader in cloud, announces that it has signed a binding agreement to acquire Dragon LLM, an AI model fine-tuning platform designed for regulated industries. This transaction aims to strengthen OVHcloud’s expertise in generative AI.             Dragon LLM          Founded under the name Lingua Custodia to target the financial sector, Dragon LLM is a French company that develops specialized, sovereign generative AI models. As a winner of the Large AI Grand Challenge organized by the European Commission, Dragon LLM develops high-performance, cost-effective AI models tailored to business needs and deployable on local infrastructure. Based in Paris, the company aims to build a useful, responsible, and efficient European AI that serves businesses and supports the...

Continue reading

Mowi ASA: Integrated Annual Report 2025

Mowi has today published its 2025 Integrated Annual Report, including sustainability reporting and complete 2025 annual accounts with notes. The integrated report is attached, available in European Single Electronic Format (ESEF) and has been published on www.mowi.com/investors/reports/ This information is subject to the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.         AttachmentsMowi Annual Report 2025mowi-2025-12-31-1-en

Continue reading

Yimutian Inc. Announces Resignation of Independent Director

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) — Yimutian Inc. (NASDAQ: YMT) (the “Company”) announced that Junchen Sun, an independent director of the Company’s Board of Directors, has resigned from the Board, effective March 17, 2026. Mr. Sun’s decision to resign is due to personal reasons. The Company and the Board would like to thank Mr. Sun for his service and contributions to the Company during his tenure on the Board. The Nominating and Corporate Governance Committee of the Board will oversee the process for identifying a potential replacement, and the Company will make appropriate disclosures in accordance with applicable law and the rules of the U.S. Securities and Exchange Commission and the listing standards of Nasdaq. About Yimutian Inc.Yimutian Inc, is a leading agricultural B2B platform in mainland China. Over a decade,...

Continue reading

Rogers Communications Inc. Announces Pricing of Public Offering of US$750 million Fixed-to-Fixed Rate Subordinated Notes and Canadian Private Placement of Cdn$1.25 billion Fixed-to-Fixed Rate Subordinated Notes

TORONTO, March 24, 2026 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (“RCI”) announced today that it has priced:a U.S. public offering of US$750 million of 6.875% fixed-to-fixed rate subordinated notes due 2056 (the “US Notes”); and a Canadian private placement of $1.25 billion of 6.250% fixed-to-fixed rate subordinated notes due 2056 (the “Cdn Notes” and, together with the US Notes, the “Notes”).The net proceeds from the issuance of the US Notes and the issuance of the Cdn Notes will be approximately US$740 million and $1.24 billion, respectively. RCI expects to use the net proceeds from both offerings to repay certain outstanding indebtedness of RCI. The offering of the US Notes and the offering of the Cdn Notes are each expected to close on March 27, 2026. The US Notes will be issued pursuant...

Continue reading

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock at a public offering price per share of $70.00. The aggregate gross proceeds to Apogee from the offering are expected to be approximately $350 million before deducting underwriting discounts and commissions and other offering expenses payable by Apogee. The offering is expected to close on March 26, 2026, subject to the satisfaction of customary closing conditions. In addition, Apogee has granted the underwriters an option for...

Continue reading

Digital Realty Delivers Colocation Infrastructure Support to Samsung Electronics in Seoul

SEOUL, South Korea, March 25, 2026 (GLOBE NEWSWIRE) — Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced that it is providing enterprise-grade data center infrastructure to Samsung Electronics at its ICN10 data center in Seoul. Through this engagement, Digital Realty is supporting Samsung Electronics’ enterprise IT operations by delivering stable and scalable colocation infrastructure. Modern enterprise IT environments require secure, scalable, and resilient infrastructure capable of supporting large-scale data processing, high availability requirements, and long-term operational stability. Digital Realty’s ICN10 data center is designed to meet these needs, offering robust power, cooling, security, and operational reliability for mission-critical enterprise environments. Digital...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.